Testicular tumors
Testicular tumors account for 1% to 2% of male malignant tumors and are divided into primary and secondary types. The vast majority are primary and are divided into two categories: germ cell tumors and non-germ cell tumors. Germ cell tumors occur in the reproductive epithelium of the seminiferous tubules, accounting for 90% to 95% of testicular tumors, of which seminoma is the most common, grows slowly, and generally has a good prognosis; non-seminomas such as embryonal carcinoma, teratoma, choriocarcinoma, etc. are relatively rare, but have a high degree of malignancy, early lymphatic and hematogenous metastasis, and a poor prognosis. Non-germ cell tumors occur in testicular interstitial cells, accounting for 5% to 10%, and are derived from testicular interstitial cells such as fibrous tissue, smooth muscle, blood vessels and lymphatic tissue. Secondary testicular tumors are relatively rare.
Related Drugs
Mitoxantrone Hydrochloride for Injection
Indication: It is mainly used for malignant lymphoma, breast cancer and acute leukemia. It also has certain effects on lung cancer, melanoma, soft tissue sarcoma, multiple myeloma, liver cancer, colorectal cancer, kidney cancer, prostate cancer, endometrial cancer, testicular tumors, ovarian cancer and head and neck cancer.
Cyclophosphamide for injection
Indication: This product is a widely used anticancer drug. It has a good effect on malignant lymphoma, acute or chronic lymphocytic leukemia, and multiple myeloma. It also has a certain effect on breast cancer, testicular tumors, ovarian cancer, lung cancer, head and neck squamous cell carcinoma, nasopharyngeal carcinoma, neuroblastoma, rhabdomyosarcoma and osteosarcoma.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Cyclophosphamide for injection
Indication: This product is a widely used anticancer drug. It has good effects on malignant lymphoma, acute or chronic lymphocytic leukemia, and multiple myeloma. It also has certain effects on breast cancer, testicular tumors, ovarian cancer, lung cancer, head and neck squamous cell carcinoma, nasopharyngeal carcinoma, neuroblastoma, rhabdomyosarcoma, and osteosarcoma.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Cyclophosphamide for injection
Indication: This product is a widely used anticancer drug. It has a good effect on malignant lymphoma, acute or chronic lymphocytic leukemia, and multiple myeloma. It also has a certain effect on breast cancer, testicular tumors, ovarian cancer, lung cancer, head and neck squamous cell carcinoma, nasopharyngeal carcinoma, neuroblastoma, rhabdomyosarcoma and osteosarcoma.
Manufacturer:
Shanxi PUDE Pharmaceutical Co., Ltd.
Cyclophosphamide for injection
Indication: This product is a widely used anticancer drug. It has a good effect on malignant lymphoma, acute or chronic lymphocytic leukemia, and multiple myeloma. It also has a certain effect on breast cancer, testicular tumors, ovarian cancer, lung cancer, head and neck squamous cell carcinoma, nasopharyngeal carcinoma, neuroblastoma, rhabdomyosarcoma and osteosarcoma.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Cyclophosphamide for injection
Indication: This product is a widely used anticancer drug. It has a good effect on malignant lymphoma, acute or chronic lymphocytic leukemia, and multiple myeloma. It also has a certain effect on breast cancer, testicular tumors, ovarian cancer, lung cancer, head and neck squamous cell carcinoma, nasopharyngeal carcinoma, neuroblastoma, rhabdomyosarcoma and osteosarcoma.
Cyclophosphamide for injection
Indication: This product is a widely used anticancer drug. It has a good effect on malignant lymphoma, acute or chronic lymphocytic leukemia, and multiple myeloma. It also has a certain effect on breast cancer, testicular tumors, ovarian cancer, lung cancer, head and neck squamous cell carcinoma, nasopharyngeal carcinoma, neuroblastoma, rhabdomyosarcoma and osteosarcoma.
Manufacturer:
Han Hui Pharmaceuticals Company Limited
Cyclophosphamide for injection
Indication: This product is a widely used anticancer drug. It has a good effect on malignant lymphoma, acute or chronic lymphocytic leukemia, and multiple myeloma. It also has a certain effect on breast cancer, testicular tumors, ovarian cancer, lung cancer, head and neck squamous cell carcinoma, nasopharyngeal carcinoma, neuroblastoma, rhabdomyosarcoma and osteosarcoma.
Manufacturer:
Han Hui Pharmaceuticals Company Limited
Mitoxantrone Hydrochloride Injection
Indication: It is mainly used for malignant lymphoma, breast cancer and acute leukemia. It also has certain effects on lung cancer, melanoma, soft tissue sarcoma, multiple myeloma, liver cancer, colorectal cancer, kidney cancer, prostate cancer, endometrial cancer, testicular tumors, ovarian cancer and head and neck cancer.
Manufacturer:
Chengdu Beite Denuo Pharmaceutical Co., Ltd.